{"id":952051,"date":"2026-04-16T11:29:43","date_gmt":"2026-04-16T15:29:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/"},"modified":"2026-04-16T11:29:43","modified_gmt":"2026-04-16T15:29:43","slug":"ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/","title":{"rendered":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026"},"content":{"rendered":"<h2>\nConference call scheduled for 4:30 p.m. Eastern Time<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>WALTHAM, Mass., April  16, 2026  (GLOBE NEWSWIRE) &#8212; Ardelyx, Inc. (Nasdaq: ARDX) (\u201cArdelyx\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026.<\/p>\n<p>\n        <strong>Webcast Information<\/strong><br \/>\n        <br \/>A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yhu3M27JetvHznQcFQV340XL1HPx3ZNnIMlEgKuL5qDbJhiab84b9BrDmM38_GTBE5Rnp_WdStARnN8QOAmmhw7v9lGso_UD4bfiyEI_MhY=\" rel=\"nofollow\" target=\"_blank\">www.ardelyx.com<\/a>.<\/p>\n<p>An archived replay of the webcast and related presentation materials will be available on the Company\u2019s website following the event.<\/p>\n<p>\n        <strong>Conference Call Details<\/strong><br \/>\n        <br \/>Domestic (toll-free): 877-346-6112<br \/>International (toll): +1 848-280-6350<\/p>\n<p>\n        <strong>About Ardelyx<\/strong>\n      <\/p>\n<p>Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA<sup>\u00ae<\/sup> (tenapanor) and XPHOZAH<sup>\u00ae<\/sup> (tenapanor). The company\u2019s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx works with its partners to develop and commercialize its products outside of the United States. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=htg_O9sY5QsL8FhQFCyqR6hyCs5arEUmDnqRxz-cTwCY255GLsEDvDJcm4n-P_x2jnnfBPhPbctASwAN41B8AAEI_xIYn-zQ9EhBP-yw6Dw=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ardelyx.com\/<\/a> and connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NoVPOO2smPiyXMjFZAGiD69tNf2xJOQRxNRkZr8hPi282sxheAbRnss0WV_baYNrNn2gmeRbNagptwMLO_4PB2fAEIZq481EPvN3RnSDirKsazwaUVcIjsuRA0CxfUq9\" rel=\"nofollow\" target=\"_blank\">X (formerly known as Twitter)<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8eAhfhc-Tk5aUmQPFTU-Yd4iqxlHAaW3fqx9yuMyRBE1OkO_CQBtD8uO_djel3HcA8J2tQY5szU5wUd9A5OGZdSLTcnMijvwiu09cEoUnNA=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j5Xx1QFMbnm-ei0BEGsN8VZTMiQw1XC8Xego4XUVPo7tNjR_JNiOiIM5wYOc_94_2RcL31XUbHMdjr7tPYjCGM8G4VFJVuz09B_MR_9_2WY=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Lisa Caperelli <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eo2Nu0aP_zsc-l1uK9beR_pUI66y7UchnPY3FMMUqkaPn_w6SqgZIKjSCzoV5MuN2LI2ebJrXD-1VomdjhFjarnFN18bv2ZEel6aEs595t0=\" rel=\"nofollow\" target=\"_blank\">lcaperelli@ardelyx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDc3N2Y5ZTgtYjFkMi00MzVmLWE5NjgtOTAyZjhlNmVkYWVhLTEwMTY5ODEtMjAyNi0wNC0xNi1lbg==\/tiny\/Ardelyx-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx, Inc. (Nasdaq: ARDX) (\u201cArdelyx\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-952051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx, Inc. (Nasdaq: ARDX) (\u201cArdelyx\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; Continue reading &quot;Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-16T15:29:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026\",\"datePublished\":\"2026-04-16T15:29:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/\",\"name\":\"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\",\"datePublished\":\"2026-04-16T15:29:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk","og_description":"Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) &#8212; Ardelyx, Inc. (Nasdaq: ARDX) (\u201cArdelyx\u201d or the \u201cCompany\u201d), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026. Webcast Information A live webcast of the conference call and accompanying slides will be available in the \u201cEvents and Presentations\u201d section under \u201cNews and Events\u201d within the Investors section of the Company\u2019s website at www.ardelyx.com. An archived replay of the webcast &hellip; Continue reading \"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-16T15:29:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026","datePublished":"2026-04-16T15:29:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/","name":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=","datePublished":"2026-04-16T15:29:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4OTY1NiM3NTM0ODUzIzIwMDU0MDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ardelyx-to-report-first-quarter-2026-financial-results-on-april-30-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=952051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=952051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=952051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=952051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}